Mahesh Kudrimoti

Papers

Total Citations

H-Index

About

Mahesh Kudrimoti is a leading radiation oncologist whose research focuses on optimizing treatment strategies for head and neck cancers, particularly oropharynx squamous cell carcinoma. His most impactful work directly compares surgical and non-surgical approaches for resectable oropharynx cancer, specifically evaluating outcomes between transoral robotic surgery (TORS) and definitive chemoradiation. This seminal 2019 study, cited over 40 times, provides critical evidence guiding clinical decision-making for patients and oncologists, highlighting the balance between survival outcomes, functional preservation, and quality of life. Dr. Kudrimoti’s contributions help define modern multidisciplinary management of HPV-related oropharynx cancers, addressing the growing need for de-escalation strategies that minimize treatment toxicity without compromising cure rates. His research is widely referenced in clinical guidelines and has influenced practice patterns in academic and community settings. Through rigorous comparative effectiveness studies, Dr. Kudrimoti continues to shape the evidence base for personalized treatment in head and neck oncology, making him a respected voice in the field.